Returns Chart

Key Stats

Customize

Basic Info

Investment Strategy
The trust seeks total return potential primarily through capital appreciation. There is no guarantee that the investment objectives of the trust will be achieved.
General
Security Type Unit Investment Trust
Oldest Share Symbol F000016ZD9
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index --
Prospectus Objective Specialty - Health
Fund Owner Firm Name SmartTrustĀ®
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

Net Fund Flows Versus Category

1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
No Data Available
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: --
-4.645B Category Low
7.623B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
Date Unavailable

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of July 29, 2021. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Edit comparables
Name
2014
2015
2016
2017
2018
2019
2020
YTD
--
--
--
--
--
--
--
--
4.94%
-0.87%
7.51%
22.40%
-8.71%
27.67%
15.90%
15.84%
--
--
--
--
--
--
--
-12.70%
--
--
--
--
--
--
54.43%
-3.73%
--
--
--
--
--
--
-4.99%
-23.48%
29.30%
15.17%
-16.03%
45.83%
-0.15%
58.74%
37.04%
-18.78%
As of July 29, 2021.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (7-29-21) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of July 23, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth --
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth --
Forecasted Earnings Growth --
Forecasted Revenue Growth Upgrade
As of July 23, 2021

Asset Allocation

As of July 23, 2021.
Type % Net % Long % Short
Cash 0.00% Upgrade Upgrade
Stock 100.0% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
Biohaven Pharmaceutical Holding Co Ltd 6.15% 126.01 -0.10%
Cortexyme Inc 5.46% 56.51 0.86%
Inovio Pharmaceuticals Inc 4.81% 8.40 -1.18%
Reata Pharmaceuticals Inc A 4.66% 125.31 -2.15%
Aurinia Pharmaceuticals Inc 4.13% 16.76 -3.51%
ACADIA Pharmaceuticals Inc 4.01% 21.63 -2.96%
Regenxbio Inc 3.63% 32.32 -0.71%
Karyopharm Therapeutics Inc 3.62% 8.33 -0.48%
Myovant Sciences Ltd 3.48% 20.52 2.70%
Kiniksa Pharmaceuticals Ltd Class A 3.48% 15.33 2.68%

Fees & Availability

Fees
Actual 12B-1 Fee --
Actual Management Fee --
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load Upgrade
Maximum Deferred Load Upgrade
Maximum Redemption Fee --
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment Upgrade
Minimum Subsequent Investment Upgrade

Basic Info

Investment Strategy
The trust seeks total return potential primarily through capital appreciation. There is no guarantee that the investment objectives of the trust will be achieved.
General
Security Type Unit Investment Trust
Oldest Share Symbol F000016ZD9
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index --
Prospectus Objective Specialty - Health
Fund Owner Firm Name SmartTrustĀ®
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (7-29-21) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of July 23, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth --
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth --
Forecasted Earnings Growth --
Forecasted Revenue Growth Upgrade
As of July 23, 2021

Fund Details

Key Dates
Inception Date 5/4/2021
Termination Date 5/4/2023
Last Annual Report Date --
Last Prospectus Date --
Share Classes
F000016ZDA --
F000016ZDD --
SMHCKX --
Attributes
Enhanced Index Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No